Jonathan Baktari MD

Jonathan Baktari MD brings over 20 years of clinical, administrative and entrepreneurial experience. He has been a triple board-certified physician with specialties in internal medicine, pulmonary and critical care medicine.

Dr. Baktari was formerly the Medical Director of The Valley Health Systems, Anthem Blue Cross Blue Shield and Culinary Health Fund. He also served as clinical faculty for several medical schools, including the University of Nevada and Touro University.

Currently, Dr. Baktari is the CEO of e7 Health and US Drug Test Centers. 

RECIPIENT OF

vegas inc logo

TOP TECH AWARD IN HEALTHCARE

Media & Interviews

Play Video

CDC Acknowledges Covid-19 is airborne Disease

May 10, 2021
Play Video

Children wearing Masks in Schools

Jul 12, 2021
Play Video

Pulmonary and Critical Care Expert Discusses Blood Clots and COVID-19 Vaccines

April 28, 2021

Featured Press Articles

You asked: Is it safe to travel to a music festival?

Oct 7, 2021

DNR Orders Have Unintended Negative Consequences, Study Shows

Sept 3, 2021

What is the new coronavirus Delta variant, and should Americans be worried?

June 11, 2021

Latest Episode Of Baktari MD

Play Video

Episode #20 - NEW Study Released About the COVID-19 PILL From MERCK: Molnupiravir - What you NEED to KNOW

Episode Description – In today’s episode, I use my biochemistry background along with my many years of experience in the medical field to dissect their study, what it could mean for the future of the Coronavirus Pandemic and explain just how Molnupiravir works. Is the COVID-19 pill a replacement to the mRNA vaccines? Is there a risk of Molnupiravir affecting your own DNA? Could this pill dramatically reduce the deaths from COVID-19?

SUBSCRIBE:
Jonathan Baktari MD Media Coverage
Jonathan Baktari MD Pro Shot
Jonathan Baktari MD Media Coverage
Jonathan Baktari MD Media Coverage
Jonathan Baktari MD Media Coverage
Jonathan Baktari MD
Jonathan Baktari MD Head Shot

BAKTARIMD NEWSLETTER

Sign up for my free newsletter and
get exclusive access to medical insights.